Goosehead Insurance Reports Mixed Q4 & Full Year 2025 Results, Expands Share Repurchase by $180M, and Appoints New Director

summarizeSummary

Goosehead Insurance announced Q4 and full year 2025 results, reporting strong revenue growth but a decline in net income and EPS, while also expanding its share repurchase program by a significant $180 million and appointing a new independent director.

check_boxKey Events

• Mixed Q4 and Full Year 2025 Financial Results

  The company reported a 12% increase in Q4 total revenues to $105.3 million and a 16% increase for the full year 2025. Adjusted EBITDA grew 5% in Q4 to $39.2 million and 14% for the full year to $113.6 million. However, net income for Q4 decreased to $20.8 million from $23.8 million, and full year net income was $44.5 million, down from $49.1 million in 2024, leading to a 17% decline in Q4 EPS to $0.50.

• Significant Share Repurchase Program Expansion

  Goosehead's Board of Directors authorized an additional $180.0 million for share repurchases, extending the program through May 1, 2027. This represents a substantial capital allocation decision, following $81.7 million in repurchases during 2025.

• 2026 Financial Outlook Provided

  The company issued guidance for the full year 2026, expecting total revenues to grow organically between 10% and 19%, and total written premiums to increase between 12% and 20%.

• New Independent Director Appointed to Board

  Louis Goldberg, a former senior partner at Davis Polk with over 28 years of experience in board advisory practice, was appointed to the Board of Directors and the Nominating and Governance Committee, effective February 18, 2026. Thomas McConnon will roll off the Board as his term expires, with no reported disputes.

auto_awesomeAnalysis

Goosehead Insurance reported mixed financial results for Q4 and full year 2025, with strong revenue growth but a decline in net income and EPS. Total revenues increased 12% in Q4 and 16% for the full year, while Adjusted EBITDA also saw healthy growth. However, net income and EPS decreased year-over-year. The company provided a 2026 outlook projecting continued revenue and written premium growth. A highly significant development is the expansion of the share repurchase authorization by an additional $180.0 million, representing a substantial commitment to shareholder returns and signaling management's confidence in the company's valuation. This capital allocation decision, alongside the appointment of an experienced independent director, Louis Goldberg, to the Board, provides a positive strategic outlook despite the recent EPS dip.